Does Anemia Have a Potential Effect on Type 2 Hepatorenal Syndrome?
Table 5
Clinical and biological features of survivor and nonsurvivor patients with type 2 HRS.
HRS survivors
HRS nonsurvivors
Age (median years)
73.66 ± 10.11
65.66 ± 11.16
0.333
Gender (M/F)
3/0
4/2
0.257
Hemoglobin (g/dL)
9.9 ± 3.1
6.48 ± 1.36
0.038
Hematocrit (%)
33.33 ± 1.52
27.16 ± 7.08
0.089
Creatinine (μmol/l)
263.66 ± 159.15
256.83 ± 131.56
0.947
Total bilirubin
97.33 ± 77.46
82.00 ± 50.05
0.725
Albumin (g/dL)
28.11 ± 2.42
32.77 ± 2.73
0.098
CTP score
9.33 ± 1.52
10.00 ± 1.26
0.506
MELD score
21.00 ± 5.00
23.66 ± 4.32
0.432
HRS, hepatorenal syndrome; M, male; F, female; INR, international normalized ratio; CTP, Child–Turcotte–Pugh; MELD, model of end-stage liver disease. .
